Literature DB >> 28811959

T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma.

Daniele Maggioni1, Lorenzo Pignataro2, Werner Garavello3.   

Abstract

Head and neck squamous cell carcinoma (HNSCC) is one of the most diffused cancer types, characterized by a high reoccurrence rate, mainly due to the inability of current therapeutic approaches to completely eradicate cancer cells. HNSCC patients often have defective immune functions, thus allowing cancer immune escape and cancer spreading. Particularly important in driving immune escape during HNSCC progression are T-helper and T-regulatory cells. New insights into their mechanisms of action might support the development of effective and long-lasting immunotherapy.

Entities:  

Keywords:  HNSCC; Tregs; immune escape; immunotherapy

Year:  2017        PMID： 28811959      PMCID： PMC5543829          DOI： 10.1080/2162402X.2017.1325066

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN： 2162-4011            Impact factor:   8.110


  59 in total

Review 1.  Multi-tasking of helper T cells.

Authors:  Yisong Y Wan
Journal:  Immunology       Date:  2010-06       Impact factor: 7.397

2.  Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer.

Authors:  Gregory T Wolf; Willard E Fee; Robert W Dolan; Jeffrey S Moyer; Michael J Kaplan; Paul M Spring; James Suen; Daniel E Kenady; Jason G Newman; William R Carroll; M Boyd Gillespie; Scott M Freeman; Lorraine Baltzer; Terry D Kirkley; Harvey J Brandwein; John W Hadden
Journal:  Head Neck       Date:  2011-01-31       Impact factor: 3.147

Review 3.  The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications.

Authors:  Panagiota Economopoulou; Christos Perisanidis; Evaggelos I Giotakis; Amanda Psyrri
Journal:  Ann Transl Med       Date:  2016-05

4.  Increased prevalence of T(H)17 cells in the peripheral blood of patients with head and neck squamous cell carcinoma.

Authors:  Chen Li; Yifang Zhao; Wenfeng Zhang; Wei Zhang
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2011-03-31

Review 5.  Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.

Authors:  Yechiel Becker
Journal:  Anticancer Res       Date:  2006 Mar-Apr       Impact factor: 2.480

6.  Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.

Authors:  Fumiko Ichihara; Koji Kono; Akihiro Takahashi; Hiromichi Kawaida; Hidemitsu Sugai; Hideki Fujii
Journal:  Clin Cancer Res       Date:  2003-10-01       Impact factor: 12.531

7.  CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancer.

Authors:  Kazuaki Chikamatsu; Koichi Sakakura; Goro Takahashi; Atsushi Okamoto; Nobuhiko Furuya; Theresa L Whiteside; Albert B DeLeo; Keisuke Masuyama
Journal:  Cancer Immunol Immunother       Date:  2009-01-28       Impact factor: 6.968

8.  Serum biomarkers in head and neck squamous cell cancer.

Authors:  Nadine M Kaskas; Tara Moore-Medlin; Gloria B McClure; Oleksandr Ekshyyan; John A Vanchiere; Cherie-Ann O Nathan
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-01       Impact factor: 6.223

9.  Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study.

Authors:  Gregory T Wolf; Douglas B Chepeha; Emily Bellile; Ariane Nguyen; Daffyd Thomas; Jonathan McHugh
Journal:  Oral Oncol       Date:  2014-10-03       Impact factor: 5.337

10.  Adenosine and prostaglandin e2 production by human inducible regulatory T cells in health and disease.

Authors:  Theresa L Whiteside; Edwin K Jackson
Journal:  Front Immunol       Date:  2013-07-25       Impact factor: 7.561
View more
  15 in total

1.  Identification of a Prognostic Model Based on Fatty Acid Metabolism-Related Genes of Head and Neck Squamous Cell Carcinoma.

Authors:  Peiyu Du; Yue Chai; Shimin Zong; Jianxin Yue; Hongjun Xiao
Journal:  Front Genet       Date:  2022-06-30       Impact factor: 4.772

Review 2.  Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment.

Authors:  Sabah Nisar; Parvaiz Yousuf; Tariq Masoodi; Nissar A Wani; Sheema Hashem; Mayank Singh; Geetanjali Sageena; Deepika Mishra; Rakesh Kumar; Mohammad Haris; Ajaz A Bhat; Muzafar A Macha
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

3.  Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer.

Authors:  Jian-Feng Liu; Lei Wu; Lei-Lei Yang; Wei-Wei Deng; Liang Mao; Hao Wu; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  J Exp Clin Cancer Res       Date:  2018-03-05

4.  Cancer-associated fibroblast-derived interleukin-1β activates protumor C-C motif chemokine ligand 22 signaling in head and neck cancer.

Authors:  Yu-Hsuan Huang; Che-Ying Chang; Yi-Zih Kuo; Wei-Yu Fang; Hung-Ying Kao; Sen-Tien Tsai; Li-Wha Wu
Journal:  Cancer Sci       Date:  2019-08-02       Impact factor: 6.716

5.  Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma.

Authors:  Yangyang She; Xiangbo Kong; Yaping Ge; Ping Yin; Zhiyong Liu; Jieyu Chen; Feng Gao; Silian Fang
Journal:  Cancer Cell Int       Date:  2020-01-17       Impact factor: 5.722

6.  Bioinformatics Analyses Indicate That Cathepsin G (CTSG) is a Potential Immune-Related Biomarker in Oral Squamous Cell Carcinoma (OSCC).

Authors:  Guang-Zhao Huang; Qing-Qing Wu; Ze-Nan Zheng; Ting-Ru Shao; Fei Li; Xin-Yan Lu; Heng-Yu Ye; Gao-Xiang Chen; Yu-Xing Song; Wei-Sen Zeng; Yi-Long Ai; Xiao-Zhi Lv
Journal:  Onco Targets Ther       Date:  2021-02-25       Impact factor: 4.147

Review 7.  Tumor immune microenvironment in head and neck cancers.

Authors:  Samantha M Y Chen; Alexandra L Krinsky; Rachel A Woolaver; Xiaoguang Wang; Zhangguo Chen; Jing H Wang
Journal:  Mol Carcinog       Date:  2020-02-03       Impact factor: 4.784

Review 8.  Treg: A Promising Immunotherapeutic Target in Oral Diseases.

Authors:  Yujing Zhang; Jihua Guo; Rong Jia
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

9.  CD8+ and Regulatory T cells Differentiate Tumor Immune Phenotypes and Predict Survival in Locally Advanced Head and Neck Cancer.

Authors:  Alessia Echarti; Markus Hecht; Maike Büttner-Herold; Marlen Haderlein; Arndt Hartmann; Rainer Fietkau; Luitpold Distel
Journal:  Cancers (Basel)       Date:  2019-09-19       Impact factor: 6.639

Review 10.  Immune Response Against Head and Neck Cancer: Biological Mechanisms and Implication on Therapy.

Authors:  Francesco Perri; Franco Ionna; Francesco Longo; Giuseppina Della Vittoria Scarpati; Carmine De Angelis; Alessandro Ottaiano; Gerardo Botti; Francesco Caponigro
Journal:  Transl Oncol       Date:  2019-12-21       Impact factor: 4.243
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.